alexa Sally Stone | GlaxoSmithKline
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Sally Stone

GlaxoSmithKline, UK
Sally Stone is the head of Digital CoE and Commerial Innovation at GlaxoSmithKline Southall, United Kingdom. She had been instrumental in driving the embedding of digital channels across the European pharma business, Delivering capability development for GSK European employees, establishing a robust governance framework for the implementation and delivery of digital engagement. She has also lead European engagement in development and adoption of Global Digital Service and startegy development for commercial innovation and project initiation
Research Interest
Diabetes Dosing BA/BE studies

Bioequivalence and Dose Proportionality of Inhaled Fluticasone Furoate

Ann Allen, Jo Bal, Alison Moore, Sally Stone and Lee Tombs

Research Article: J Bioequiv Availab

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version